Accolade hits near 5-month low on wider Q2 loss

Accolade

08/10/2021 16:27

** Shares of healthcare information technology provider
 ACCD.O  fall as much as ~5% to hit a near 5-month low $38
    ** Stock, last down ~2%, set to fall for a third straight
session
    ** ACCD on Thursday aftermarket posted a wider-than-expected
Q2 loss  urn:newsml:reuters.com:*:nASA02N1E
    ** Co reported loss per share of 97 cents vs analysts'
estimate of a loss of 56 cents per share - Refinitiv IBES data
    ** ACCD, however, said Q2 revenue nearly doubled to $73.3
mln, beating estimates of $70.5 mln
    ** At least 5 brokerages lower their PTs on ACCD to between
$52 and $62 after co's results; median PT among 12 analysts is
$60 
    ** Including Friday's losses, ACCD down ~10% YTD

 (Reporting by Deborah Sophia in Bengaluru)
 ((DeborahMary.Sophia@thomsonreuters.com;))